Campto

Campto Contraindications

irinotecan

Manufacturer:

Pfizer
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Contraindications
CAMPTO is contraindicated in patients with: A chronic inflammatory bowel disease and/or a bowel obstruction (see Precautions).
A history of severe hypersensitivity reactions to irinotecan hydrochloride trihydrate or to one of the excipients of CAMPTO (see Precautions).
In pregnant or breast feeding women.
In patient with bilirubin >3 times the ULN (see Precautions).
In patient with a severe bone marrow failure.
In patients presenting a risk factor, particularly those with a WHO performance status >2.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in